The Drug Price Competition and Patent Term Restoration Act of 1984 (the Hatch-Waxman Act) expedites generic drug approval after the patent and market exclusivity periods end for branded drugs. To increase the level of competition between branded and generic drugs, the Hatch-Waxman Act …
